Partnering Opportunity: Effervescent Powders for Inhalation

Summary of the technology

University of Alberta and Alberta Health Services researchers have jointly developed a new type of dry-powder inhalable carrier particle with an active release mechanism to disperse therapeutics more effectively. Most advanced product candidate based on this delivery system is an inhalable effervescent doxorubicin nanoparticle formulation; it demonstrated significantly improved survival time in a small cell lung cancer mouse model.

University of Alberta, Technology Transfer Services

Details of the Technology Offer

The respiratory tract is an effective administration route for drug delivery to the lung as well as an emerging delivery option for systemic therapeutics. University of Alberta and Alberta Health Services researchers have jointly developed a new type of dry-powder inhalable carrier particle with an active release mechanism to disperse therapeutics more effectively. Particle size may be customized to target specific areas of the respiratory tract including the deep regions of the lung. Similar to the effervescent technology commonly used in oral drug formulations, the particles effervesce on contact with moisture to provide a localized burst release of drug. This new carrier has been used to create an active-release inhalable delivery vehicle for PBCA nanoparticles. A 12-week toxicity study of the carrier-PBCA nanoparticle formulation administered to mice by inhalation showed no negative effects. The most advanced product candidate based on this delivery system is an inhalable effervescent doxorubicin nanoparticle formulation, which has demonstrated significantly improved survival time in a mouse model of small cell lung cancer.

COMPETITIVE ADVANTAGE

  • Aerosol may reduce systemic side effects and increase effectiveness of doxorubicin for lung cancer.
  • Spray-drying process is cost-effective and scalable.
  • Carrier particles work with conventional dry powder inhalers; carrier ingredients approved for human use.

Intellectual property status

Attached documents

Related Keywords

  • Biological Sciences
  • Medicine, Human Health
  • Genetic Engineering / Molecular Biology
  • Medical Health related
  • Oncology
  • nanoparticle
  • drug deliver
  • small cell lung cancer

About University of Alberta, Technology Transfer Services

Transforming discoveries and innovations into reality is a complex and lengthy process. UAlberta’s Technology Transfer Services (TTS) team helps facilitate this journey. Part of the Vice-President (Research and Innovation) portfolio, TTS helps researchers, postdoctoral fellows, staff and students transform innovations and discoveries into reality—moving them out of the university to benefit society, the economy, the world.

University of Alberta, Technology Transfer Services

Never miss an update from University of Alberta, Technology Transfer Services

Create your free account to connect with University of Alberta, Technology Transfer Services and thousands of other innovative organizations and professionals worldwide

University of Alberta, Technology Transfer Services

Send a request for information
to University of Alberta, Technology Transfer Services

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support